Analysis of microsatellite instability (MI) and loss of heterozygosity (LOH) is recommended for screening patients with sporadic and hereditary malignancies. This study shows an application of a fluorescent hexaplex PCR system for microsatellite typing on A.L.F. DNA Sequencer (Pharmacia Biotech). This technique detects changes in microsatellites providing a time-efficient, reliable and accurate method for MI and LOH analyses. The Fragment Manager software was used for automated size calculation and quantitation of DNA fragments, enabling rapid and precise measurement of allelic ratios. We examined 70 breast cancer and 70 control DNA specimens, classified all the patterns of microsatellite alterations, and set up MI and LOH assessment criteria for the automated multiplex fluorescent method.
was shown to be caused by a germline mutation in mismatch-repair genes (Aaltonen et al., 1993; Papadopoulos et al., 1994) . MI has been detected in a wide variety of human neoplasmic tumors, both hereditary and sporadic, and is used as a diagnostic criterion for mismatch repair deficiency (Aaltonen et al., 1993; Papadopoulos et al., 1994; Wooster et al., 1994a; Yee et al., 1994) .
Analysis of the highly polymorphic microsatellite loci not only provides information about MI, but also allows the detection of allelic deletion in tumor cells. Loss of heterozygosity can only be assayed in heterozygous loci. Tumor suppressor genes are generally inactivated by an intragenic mutation within one allele and the subsequent loss of the corresponding (wild) allele, resulting in a condition termed "loss of heterozygosity" (LOH) (Knudson, 1993) . Somatic DNA alterations leading to LOH are generally more complex and may include multifocal deletion, mitotic recombination or nondisjunctional chromosomal loss, as well as gene conversion and point mutation (Meuth, 1990) . The frequent allelic loss at particular chromosomal regions in tumors indicates the presence of a tumor suppressor gene.
Loss of heterozygosity and microsatellite instability are integral parts of neoplasmic progression. Analysis of this abnormality is of great significance for clinical diagnostics and is recommended in molecular screening for both inherited and sporadic neoplasms (Jass et al., 1995; Aaltonen et al. 1998) .
This study reports a precise and efficient method for detecting microsatellite instability and LOH with the use of an automated fluorescent DNA sequencer. We used a well-characterized multiplex system enabling coamplification and typing of five short tandem repeats (STRs): HUMD1S103, HUMTH01, HUMD21S11, HUMD18S51, HUMFIBRA (FGA), and the amelogenin locus (Miścicka-Śliwka et al., 1997) . This system has been used in our laboratory in routine forensic and paternity investigations. This study presents its application in genetic analysis of 70 breast cancer specimens.
MATERIALS AND METHODS
DNA was extracted from blood and tumor tissue specimens collected from patients who were treated at the Regional Cancer Center in Bydgoszcz during the years 1997-1998. All 70 tumor samples were invasive ductal carcinomas (IDC). Tumor tissues were surgically resected and whole blood samples were obtained from corresponding patients through venipuncture. Biological samples was collected according to Approval of Independent Ethics Committee of the Ludwik Rydygier Medical University in Bydgoszcz. The tumor tissue was then snap-frozen in liquid nitrogen and stored at -70°C. Genomic DNA was extracted from tumor tissue and each corresponding whole blood sample using standard organic protocol (Sambrook et al., 1998) . DNA concentration was measured using GeneQuant DNA Calculator (Pharmacia-Biotech Uppsala, Sweden).
Amplification of a hexaplex consisting of five STR loci (HUMD1S103, HUMTH01, HUMD21S11, HUMD18S51, and HUM-FIBRA) and the amelogenin locus, HUM-AMGXY, was performed according to previously described procedure (Miścicka-Śliwka et al., 1997) . The amplified fragments were separated in 6% denaturing polyacrylamide gels on A.L.F Automated Fluorescent DNA Sequencer (Pharmacia Biotech, Uppsala, Sweden). External Size Standard 50-500 bp (Pharmacia Biotech) was used. An internal size standard was the shorter product of the amelogenin locus (106 bp). Fragment Manager software was used to measure size and signal intensity of the fluorescent PCR products. This software allows for automated linear quantitation and calculation of allelic ratios. Statistical analysis was performed using c 2 tests and Fisher exact test with the "SPSS" statistical package.
RESULTS
A multiplex PCR system was used to identify the expansion and/or deletion of five microsatellite loci: D1S103, TH01, D21S11, D18S51, and FGA, in tumor specimens. These loci were amplified from genomic DNA that had been extracted from tumor specimens and corresponding whole blood samples obtained from each patient. One fluorescent dye was used for simultaneous amplification of five STR sequences in a single reaction. The PCR products from the tumor and normal control tissue were then separated in two different lanes in the gel. We present a comparative analysis of many genetic profiles from corresponding normal and neoplasmic tissue samples and set up criteria for the assessment of MI and LOH.
The electropherograms in Fig. 1 represent a genetic profile at five microsatellite loci (D1S103, THO1, D21S11, D18S51, FGA) and the AMG locus of normal lymphocyte DNA and tumor neoplasmic DNA collected from the same patient. Loss of heterozygosity was identified when either no peak or a very weak peak (signal for one of the alleles reduced by at least 35%) was detected in the neoplasmic DNA as compared to the control lymphocyte DNA. Strength of the signal corresponding to an individual allele was defined by the software as peak height and peak area. To estimate the degree of LOH, peak areas of the alleles in a heterozygote from normal (N) and tumor sample (T) were calculated. However, one must take into account measurement errors or slight differences in the efficiency of PCR amplification. In this experiment, the relative difference in peak areas of normal heterozygotes was calculated to average 10% for all tested loci. For a few heterozygous STR loci, a higher imbalance of 25% was observed. We assumed LOH when ³35% (25% + 10%) differences between peak areas were encountered. All the results were verified by two independent PCR reactions.
The electropherograms in Figs. 1 and 2 show the relative amounts of the two corresponding alleles, indicating loss of heterozygosity. For example, in tumor samples the microsatellites D21S11 in lane 2 (Fig. 1 A, B) and D1S103, D21S11 and FGA in lane 2 (Fig.  2) , had very weak peaks at positions corresponding to the peaks of the normal allele. Therefore, LOH could be assessed and quantitated very effectively using the Fragment Manager software. Table D in Fig. 1 , and E in Fig. 2 demonstrate software quantitation and calculation of allelic ratios at the analyzed heterozygous loci.
Microsatellite instability was identified when a novel allele in tumor DNA was observed as compared to the control lymphocyte DNA.
To measure the DNA fragment size precisely, fluorescently labeled external size markers (50-500 bp) were loaded into every fifth gel lane. An internal size marker was the shorter PCR product of the amelogenin locus (106 bp), coamplified with the five microsatellite loci and coelectrophoresed. The Fragment Manager software used the internal size standard to normalize electrophoretic mobility differences between lanes. In one-color analyses, cancer and normal DNA amplicons were labeled with the same dye and separated in two different lanes of the gel. In this system, the amplified DNA fragments were measured with an accuracy of one base pair. The case shown in lane 2 of Fig. 1 was classified as MI positive because a novel allele, which was 4 bp longer than the longest allele in the normal DNA, was identified at the FGA locus in the cancer DNA. The results of fragment sizing, as well as peak height and area measurements, are tabulated in Fig. 1D . Additionally, in MI positive microsatellites, the comparison of signal detection between normal and cancer DNA revealed a decrease in signal strength for one allele in cancer DNA. Thus, the presented system efficiently detected diverse types of microsatellite changes in cancer specimens. Vol. 50 Jolanta Powierska-Czarny and others 1197 Differences between tumor and normal DNA were detected in 34 out of 70 invasive ductal carcinomas (IDC) (48%). In all, 78 alterations were detected in tumors, including microsatellite instability and loss of heterozygosity. In 26 cancer samples, changes in more than one locus were observed. In 70 IDC tumor cases, 6 (8%) were identified with somatic microsatellite instability, and 31 tumors (44%) with LOH. The results obtained are summarized in Table 1 . The potential impact of MI and LOH on tumor growth and progression of invasive ductal carcinoma was determined by simultaneous assessment of various parameters, including: patient's age, family history of breast cancer, condition of lymph nodes, and tumor grade and size (unpublished data). A statistically significant correlation was found between the occurrence of genetic alterations in microsatellites and the family history of breast cancer, patient age, and the presence of pathological lymph nodes (P < 0.05). No correlation was found with tumor size and grade (P > 0.05).
DISCUSSION
Loss of heterozygosity and microsatellite instability are integral parts of neoplastic progression, observed in hereditary nonpolyposis colorectal cancer (HNPCC) and other sporadic malignancies (Aaltonen et al., 1993; Papadopoulos et al., 1994; Wooster et al., 1994a; Yee et al., 1994) . A rapid, reliable, and easy screening method is presented for the detection of MI and LOH, based on a hexaplex PCR reaction routinely used in forensic and paternity studies. The fluorescence-based procedure does not require radioactive materials or special facilities and can be easily performed in any clinical laboratory. Six loci were amplified in one PCR reaction, using a 40 lane sequencing gel (with an external size marker loaded in every fifth lane) so that a maximum of 18 patients could be examined in one assay.
The Fragment Manager software was used to calculate the size, and peak height and area for each fluorescent product. This method enables detection of differences between neoplastic and normal tissue, providing an effective, sensitive, and accurate analysis of both MI and LOH. Previous reports point out to higher reliability of automatic fluorescent detection changes in STRs over the conventional radiolabeling methods (Toh et al., 1996; Wang et al., 1997) .
The software enabled automated linear quantitation and calculation of allelic ratios, allowing rapid identification of LOH. Molecular analyses of allelic deletion remain difficult to interpret, as samples usually contain several subpopulations of tumor cells. Frequent mixtures of tumor samples and normal cells create further difficulties for accurate interpretation (BiPche & Lidereau, 1995 tive method for the detection of changes at microsatellite loci -a single neoplastic cell can be identified among 500 normal ones, as described by Sidransky (1997) . It was observed that the detection of LOH with the use of multiplex fluorescent PCR systems was effective in tumor tissue sections. For the system used in this study, optimal template DNA concentration is 5-10 ng per 25 ml of PCR reaction volume (Miścicka-Śliwka et al., 1997) . It was found that template concentration outside the optimal range disturbed the accuracy of peak measurements for each fluorescent product and thus posed difficulties for the observation of microsatellite changes.
This highly discriminating multiplex system is sensitive enough for both personal identification and cancer cell detection. Herein described is a method for single-color detection on a single-wavelength automated DNA sequencer, which is much simpler in use than four-dye sequencers. The single-color detection system eliminates the problem of different detection sensitivities displayed by different dyes when using multi-wavelength sequencers such as ABI 373, 377 or 310. This is very important for the quantitation and calculation of allelic ratios, and facilitates measurement of allelic deletions in tumor DNA.
This study analyzed the cases of MI and LOH in microsatellites localized in five chromosomes. Alteration in the HUMFIBRA locus, located at 4q28, occurs frequently in invasive ductal carcinomas, which may suggest the importance of this chromosomal region for tumor growth (unpublished data). A high frequency of LOH detected in loci D18S51 and THO1 confirms the localization of the known suppressor genes DCC (18q) and TSG101 (11p15) in the vicinity of these loci (Fearon et al., 1990; Li et al., 1997) .
Our recent study demonstrated also that genetic alterations in microsatellites are correlated with patient age and family history of breast cancer, as well as with the presence of pathological lymph nodes (unpublished data). Germinal mutations in the BRCA1 and/or BRCA2 gene are responsible for the majority of hereditary breast cancer cases (Feunteun & Lenoir, 1996; Sobczak et al., 1997; . Recent studies on their biological functions suggest a role in monitoring and/or repair of DNA lesions (Feunteun, 1998) . Inactivation of these genes leads to genetic instability and increased mutation rate in some genes, such as the tumor suppressor genes controlling progression of the cell cycle. Our data and other studies (Aldaz et al., 1995; De Marchis et al., 1997; Sourvinos et al., 1997; Arzimanoglou et al., 1998) suggest that changes in microsatellites may predate to later mammary tumorogenesis.
The automated multiplex analysis of LOH and MI presented here can be a useful method for cancer screening (both inherited and sporadic) and has a potential prognostic value. In summary, the fluorescent multiplex technique of MI and LOH detection enables simultaneous assessment of changes in multiple loci in human tumors and has a wide range of potential applications in many clinical fields.
